Transcript Highlights:

• I don't know if it's a pharmaceutical front.
• I don't know if it's a pharmaceutical front that's paying Senator Montigny.
• I did not go into medicine to serve pharmaceutical profits. I became a doctor to help people heal.
• The only thing I was offered was a lifetime of pharmaceutical treatment.
• This bill is about funneling those millions of people back into pharmaceutical-profit medicine.

Keywords: 995, all

Summary: The committee opened a hearing of the Joint Committee on Consumer Protection and Professional Licensure and reviewed a broad agenda including credit card fees, event ticketing, music therapy licensure, senior psychologist licensure, CPA pathways, school mental health licensure, and a bill regulating alternative healing therapies. The chairs explained hearing logistics, including three-minute testimony limits and submission of written testimony, and noted that more than 70 people had signed up to testify. Legislators and advocates were heard out of order throughout the day. A major portion of the hearing focused on credit card surcharge and interchange legislation. Restaurant owners, the Massachusetts Restaurant Association, NFIB, and other small-business witnesses supported bills allowing merchants to add convenience fees and, in one proposal, preventing card companies from charging fees on tax and tip portions of transactions. They argued that swipe fees are a major and growing cost, especially for restaurants, and that Massachusetts is one of only two states that bars surcharges. Opponents from the Cooperative Credit Union Association, the Electronic Payment Coalition, and the Electronic Transactions Association warned that the proposals would create compliance burdens, fragment the payment system, raise legal preemption issues, and disrupt a system they described as efficient and secure. The committee also heard competing testimony on ticket transferability and ticket resale. Supporters, including the National Consumers League and Sports Fans Coalition, said bills on ticket transferability would protect consumers who cannot attend events and would increase competition and savings in the secondary market. Opponents, including United Musicians and Allied Workers and theater owners, argued that mandatory transferability would weaken artists’ and venues’ ability to prevent scalping and predatory resale, and that some ticket sellers should be exempt from the broader ticketing regulations. Separate testimony supported music therapy licensure, senior psychologist licensure, and new CPA education pathways, with witnesses saying these measures would expand access to care and strengthen the workforce while maintaining professional standards. The hearing also drew extensive opposition to S.261 on alternative healing therapies, with practitioners and clients arguing it would overregulate spiritual and holistic practices and was not an effective response to human trafficking concerns.

Transcript Highlights:

• And I don't like the shady influencers, gray market pharmacies, and pharmaceutical manufacturers making
• Preying on fear, profiting from rural access isolation, and selling cures with pharmaceutical advertising

Bills: HB25

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access, 1185, senate, all

Transcript Highlights:

• And I don't like the shady influencers, gray market pharmacies and pharmaceutical manufacturers are once
• existing system, preying on fear, profiting from rural access isolation, and selling cures with pharmaceutical

Bills: HB25

Keywords: ivermectin, pharmacist authority, prescription-free, healthcare regulation, patient access

Transcript Highlights:

• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• In the pharmaceutical world, the PBM negotiates rebates and pricing concessions from drug manufacturers
• Michael Cantenz, representing the Pharmaceutical Care Management Association.
• Michael canton's representing pharmaceutical care management association Thank you, Chair.
• Michael Cantenz, representing Pharmaceutical Care Management Association.

Summary: The committee first heard Senate Bill 1414 by Sen. Polsky on congenital cytomegalovirus (CMV) education. The bill would require the Department of Health, working with medical experts, to create and distribute CMV educational materials to expectant and new parents or caregivers through hospitals, birth centers, and OB/GYN practices. An amendment removed a section that would have required instruction for medical professionals, and the amended bill was reported favorably as a committee substitute. The committee then took up a block of confirmations. Appointees on tabs 2 through 7 were recommended favorably in one vote, and Chavon Harris was separately confirmed as Secretary of the Agency for Health Care Administration after extensive questioning. Senators praised her leadership and experience, while others raised concerns about Medicaid redeterminations, the state’s CORE modernization project, Hope Florida, and a DCF anti-marijuana ad campaign; Harris said she would follow up on some issues and defended the agency’s work on transparency, managed care oversight, and access to care. Her confirmation was recommended favorably, with Sen. Berman noting opposition. Several health-related bills were then heard and advanced. SB 186 by Sen. Garcia expanded epilepsy training requirements for school personnel, including charter school bus drivers, and was reported favorably. SB 902 by Sen. Garcia, after amendments narrowing dental workforce provisions and allowing certain seizure rescue medication delegation to family home health aides, was reported favorably; testimony focused on medical marijuana regulation, practitioner accountability, and concerns about park and child-care proximity restrictions. SB 196 by Sen. Sharif created a uterine fibroid research database with privacy protections and was reported favorably after emotional testimony from a patient and supporters. SB 688 by Sen. Rodriguez would reestablish licensure of naturopathic doctors; it drew both support and skepticism about diagnosis and treatment boundaries, but was reported favorably. SB 1574, Maddie’s Law, would add biliary atresia screening to newborn screening and was strongly supported by parents describing a delayed diagnosis; it was reported favorably. SB 878 on clinical laboratory personnel, SB 1092 on podiatric medicine and certain cellular/tissue-based products, and SB 1032 on medical marijuana registry timelines and veteran fee waivers were also reported favorably, while SB 1032 drew debate over longer renewal/supply periods. The committee then began SB 1760 on Medicaid oversight and program transparency, with the sponsor describing the bill’s creation of a joint legislative oversight committee and a legislative actuary.

Transcript Highlights:

• yesterday we threw wide the gates to torts, even bounty hunter cases purportedly against the pharmaceutical
• There's so much in here other than trying to stop pharmaceutical companies from shipping abortion pharmaceuticals

Transcript Highlights:

• Most of what is driving this in '27 is pharmaceuticals and places wherein the state, per state law or
• So, for example, we have some pharmaceuticals that are tied to Medicare rates.
• So, for example, we have some pharmaceuticals that are tied to Medicare rates.
• so we offset over typically over 50%, or around 50% some years, of the total expenditures on pharmaceuticals

Keywords: 989, all

Summary: The Senate Health and Welfare Committee approved the January 26 and January 27, 2026 minutes, then held a confirmation hearing for Juliet Sharon as director of the Idaho Department of Health and Welfare. Sharon outlined her background in Medicaid and health policy and described priorities including program integrity, tighter fiscal oversight, improved customer service, child welfare, disability services, and efforts to resolve long-running lawsuits. Senators asked about measurable goals, audit findings, collaboration with the disability community, and the department’s role in broader health care policy; Sharon said she expects to more than double program-integrity recoveries, that audit findings have corrective action plans but no terminations, and that the department can influence national policy by setting strong examples in Idaho. The committee then moved into the department’s Medicaid budget presentation. Sharon and Deputy Director/State Medicaid Director Sasha O’Connell explained a $107.2 million supplemental request for FY 2026 driven by caseload growth, especially in traditional Medicaid, adult disability services, and behavioral health, along with federally required rate and system changes. They also reviewed the FY 2027 request, including funding for the MMIS procurement, estate recovery contractor support, additional procurement staff, and forecast adjustments for caseload, pharmaceuticals, mandatory pricing, utilization, and provider rate changes. The department said the earlier 4% provider rate reduction and behavioral health service cuts were already producing savings, but another roughly $22 million in general funds would still be needed to balance the budget, requiring legislative direction on possible options. Senators raised concerns about the impact of rate reductions on access, especially for small home- and community-based providers, and about how audit findings and system failures were being addressed. O’Connell said the department received the most public comments it has ever seen, held some very small providers harmless, and is building access-monitoring reports and cost surveys to better track service availability. The committee also discussed a planned Medicaid pharmacy copay under House Bill 345, with the department saying it intends to implement the maximum allowable amounts. The meeting ended after Sharon answered questions about Medicaid expansion caseload trends, estate recovery, and the department’s efforts to keep the program sustainable, and the chair adjourned the committee with plans to meet again the next day.

Transcript Highlights:

• Most of what is driving this in 27 is pharmaceuticals.
• So, for example, we have some pharmaceuticals that are tied to Medicare rates.
• So, for example, we have some pharmaceuticals that are tied to Medicare rates.
• so we offset over typically over 50%, or around 50% some years, of the total expenditures on pharmaceuticals

Summary: The Senate Health and Welfare Committee approved the January 26 and January 27, 2026 minutes, then took up the gubernatorial appointment of Juliet Sharon as director of the Idaho Department of Health and Welfare. Sharon described her background in public health and Medicaid administration in Arizona, Texas, and Idaho, and outlined her priorities if confirmed: program integrity, efficient operations, clearer outcome measures, child welfare, disability services, and resolving long-running class action lawsuits. Senators asked about measurable goals, balancing compassion with fiscal responsibility, audit findings, and collaboration with the disability community. Sharon said she expects to more than double program integrity recoveries, that audit findings are being addressed through corrective action plans rather than firings, and that disability collaboration should be embedded in daily operations. Committee members also discussed Idaho’s influence on federal policy and Medicaid administration. No vote on the appointment was taken in the portion provided. The committee then heard a lengthy Medicaid budget presentation focused on the Department’s supplemental request for state fiscal year 2026 and line-item requests for 2027. Sharon and Deputy Director/State Medicaid Director Sasha O’Connell explained that the supplemental request was driven by caseload growth, especially in traditional Medicaid, adult disability services, and youth/adult behavioral health, along with federally required rate and system changes. They also reviewed the impact of the governor-directed 4% provider rate reduction and the ending of some adult behavioral health services, saying the department had already been tracking budget sustainability before the executive order. O’Connell said the rate cuts drew the most public comment the agency has ever received, especially from home- and community-based providers, and that access monitoring is being developed to track whether services remain available. For 2027, the department requested funding for MMIS procurement, estate recovery, additional procurement staff, Medicaid admin reductions, and population forecast adjustments. Sharon said the MMIS modernization is on pause because of litigation over a major contract award, but other modules are moving forward. She also said estate recovery is underperforming and could bring in more general funds with contractor support. The committee discussed pharmacy costs and a possible Medicaid copay under House Bill 345, with Sharon saying implementation is underway and O’Connell noting savings estimates are still being developed. Senators also asked about expansion Medicaid growth and whether it affects other eligibility groups; Sharon said expansion growth is leveling off and that recovery rules apply to any Medicaid member receiving long-term care services. The meeting ended without any budget votes in the excerpt provided.

Transcript Highlights:

• Were they on pharmaceutical drugs? Were they on illicit or illegal drugs?
• If we find that illegal substances or pharmaceuticals are not, I don't know.
• If illegal substances or pharmaceuticals are not a major component, then we can settle that element of
• we have not been looking at the potential impact of illegal and illicit substances as well as pharmaceutical

Summary: The Assembly Public Safety Committee heard several bills dealing with firearms, hit-and-run penalties, domestic violence, and sexually violent predator placement. AB 256 by Assemblymember DeMaio would add a one-year enhancement for certain firearm felonies involving controlled substances and require toxicology testing; supporters said it would provide transparency about the causes of gun violence, while opponents argued it duplicated existing law, was overbroad, and raised privacy concerns. AB 1281, also by DeMaio, would increase penalties for hit-and-run cases involving death or serious injury; supporters framed it as a response to a fatal case in the author’s district, while opponents said current law already provides strong penalties and the bill would remove judicial flexibility. Both bills drew no formal support beyond the author and were opposed by public defenders, civil liberties groups, and other advocates. AB 292 by Assemblymember Patterson, as amended, would increase punishment for repeat felony domestic violence offenders, including higher prison terms and a longer mandatory jail minimum for probationers with prior domestic violence convictions. The author and a survivor witness argued that early release can endanger victims and children, and the California State Sheriffs’ Association and California District Attorneys Association supported the measure. Opponents, including public defenders and advocacy groups, said existing law already escalates penalties, warned the bill could sweep too broadly or reduce flexibility, and urged more prevention-oriented responses. After discussion, the committee approved AB 292 as amended and sent it to Appropriations. AB 767 by Assemblymember Alanis would clarify that private and home-based schools, as well as daycare facilities, are covered by existing restrictions on conditional release placements for sexually violent predators. Supporters said the bill would better protect children and resolve inconsistent court interpretations, while opponents argued it could effectively bar placement in large parts of the state and undermine rehabilitation and due process. The committee passed AB 767 to Appropriations. The committee also approved the consent item AB 277. AB 1092, a vote-only reconsideration item from the prior year, was brought up without the author present and was defeated. Final reported outcomes were: AB 256 failed, AB 277 passed, AB 292 passed, AB 767 passed, AB 1281 failed, and AB 1092 failed.

Transcript Highlights:

• Last session, I sponsored House Bill 4990, which created the Texas Pharmaceutical.
• our approach to managing medication costs. together and to be able to get the best prices on pharmaceutical
• House Bill 4638, relating to the Texas Pharmaceutical Initiative.
• House Bill 4638, relating to the Texas Pharmaceutical Initiative. Passage of House Bill 4638.

Bills: SB801, SB867, SB2717, SB2919, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB111, HB112, HB121, HB126, HB146, HB186, HB223, HB229, HB322, HB367, HB500, HB521, HB640, HB705, HB783, HB1052, HB1056, HB1105, HB1106, HB1178, HB1211, HB1234, HB1306, HB1403, HB1449, HB1506, HB1661, HB1690, HB1871, HB1960, HB2017, HB2078, HB2128, HB2240, HB2243, HB2348, HB2407, HB2512, HB2820, HB2844, HB2853, HB2854, HB2885, HB3000, HB3005, HB3053, HB3057, HB3181, HB3333, HB3372, HB3425, HB3441, HB3516, HB3749, HB3783, HB3812, HB3848, HB3923, HB3963, HB4070, HB4134, HB4157, HB4158, HB4211, HB4449, HB4623, HB4638, HB4687, HB4690, HB4748, HB4749, HB4795, HB4848, HB5093, HB5115, HB5129, HB5138, HB5294, HB5616, HB5629, HB5646, HB5661, HB5672, HB5674, HB5699, HCR40, SJR5, SJR27, SJR59, SB4, SB6, SB8, SB9, SB10, SB12, SB22, SB23, SB25, SB27, SB34, SB36, SB37, SB38, SB40, SB57, SB140, SB261, SB293, SB441, SB447, SB467, SB512, SB650, SB777, SB785, SB924, SB1188, SB1281, SB1318, SB1333, SB1398, SB1448, SB1566, SB1579, SB1621, SB1723, SB1838, SB1862, SB2167, SB2405, SB2406, SB2407, SB2878, SB3059, SB3070, SB1, SB17, SB21, SB260, SB379, SB509, SB1198, SB1405, SB1506, SB1637, SB1833, SB2155, SB2308, SB2601, SB2778, HB300, HB2011, HB2525, HB5246, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3045, SB3071, HJR7, HB5115, HB3053, HB1403, HB223, HB748, HB5652, HB3395, HB180, HB1306, HB322, HB126, HB5650, HB4894, HB1629, HB5698, HB3171, HB2694, HB5664, HB4690, HB4464, HB3623, HB2520, HB2213, HB252, HB146, HB5596, HB3619, HB5320, HB5651, HB5670, HB5665, HB5437, HB5679, HB5699, HB5661, HB5662, HB5654, HB5672, HB5656, HB3812, HB3057, HB2035, HB721, HB346, HB2512, HB5695, HB5694, HB5674, HB3185, HB2348, HB1871, HB1135, HB101, HB5666, HB5677, HB5682, HB5658, HB4144, HB3642, HB3815, HB2686, HB2012, HB1960, HB227, HB654, HB1690, HB2128, HB4158, HB4630, HB1523, HB2078, HB1973, HB3333, HB3697, HB3546, HB3225, HB3181, HB2820, HB1506, HB1234, HB640, HB521, HB229, HB186, HB119, HB4795, HB4466, HB3749, HB1106, HB4, HB4170, HB3909, HB4081, HB4145, HB4157, HB4285, HB4463, HB4995, HB5138, HB5624, HB1449, HB2598, HB3629, HB4361, HB824, HB1868, HB4848, HB2243, HB40, HB117, HB3686, HB500, HB3793, HB112, HB104, HB1056, HB42, HB3000, HB100, HB2240, HB718, HB27, HB4904, HB4202, HB2853, HB5129, HB5093, HB4765, HB4748, HB4559, HB4350, HB4214, HB3388, HB3112, HB5196, HB4211, HB3516, HB3092, HB4233, HB4687, HB705, HB1094, HB2037, HB3005, HB3848, HB1105, HB121, HB3372, HB367, HB783, HB3336, HB3441, HB4449, HB5616, HB2407, HB2854, HB3425, HB5294, HB1178, HB4623, HB14, HB3963, HB1211, HB5646, HB5629, HB3783, HB4236, HB46, HB4638, HB1052, HB4070, HB5509, HB5435, HB4134, HB3923, HB3520, HB3320, HB2517, HB2488, HB5663, HB2731, HB3073, HB2655, HB2399, HB541, HB4099, HB111, HB1532, HB3483, HB2963, HB4580, HB3748, HB713, HB632, HB426, HB4730, HB127, HB5690, HB5689, HB5655, HB3385, HB2757, HB4359, HB5381, HB20, HB123, HB549, HB5606, HB2217, HB2594, HB796, HB150, HB1057, HCR141, HCR40, HCR59, HCR76, HCR81, HCR46, HCR111, HCR83, HCR84, HJR7, HB4, HB14, HB27, HB42, HB46, HB100, HB126, HB150, HB322, HB367, HB500, HB640, HB705, HB783, HB1105, HB1178, HB1211, HB1234, HB1506, HB1690, HB1871, HB2078, HB2128, HB2240, HB2243, HB2407, HB2512, HB2853, HB2854, HB3000, HB3057, HB3181, HB3372, HB3425, HB3441, HB3749, HB3783, HB3812, HB3923, HB3963, HB4070, HB4134, HB4157, HB4211, HB4449, HB4623, HB4638, HB4687, HB4748, HB4795, HB5093, HB5129, HB5616, HB5629, HB5699, HB229, HB521, HB1056, HB1106, HB5138, SR583, SCR52, HB223, HB229, HB521, HB1056, HB1106, HB1403, HB3053, HB5115, HB5138

Keywords: SB 801, birth certificate, birth record, certified copy, homeless, homelessness, unhoused, vital records, state registrar, local registrar, county clerk, fee waiver, identity documents, ID access, housing insecurity, shelter, transitional housing, Health and Safety Code, HHSC, Health and Human Services Commission

Transcript Highlights:

• requiring prescription drug manufacturers to notify the Attorney General of arrangements between pharmaceutical
• requiring prescription drug manufacturers to notify the Attorney General of arrangements between pharmaceutical

Keywords: 993, senate, all

Summary: The Senate Standing Committee on Consumer Protection held its first meeting of the year on January 28, chaired by Senator Rachel May, with Ranking Member Patricia Canzoneri-Fitzpatrick and several other senators present. Chair May said the committee would focus this session on consumer protection issues such as surveillance pricing and the use of technology to target consumers unfairly. The ranking member briefly agreed on the importance of protecting vulnerable consumers and wished the committee a successful session. The committee then considered six bills, all of which had previously passed the Senate. The measures covered school security guards (S.194B), notice to the Attorney General about arrangements that delay generic drug introductions (S.488A), warranties and protections for purchasers of new and used motor vehicles (S.5597), a cap on credit service charges in retail installment contracts (S.5600), requirements for rental helmets to address concerns about damaged helmets (S.6985), and making renewed appearance enhancement and barber licenses and certificates available online in downloadable PDF form (S.7483). There was little discussion on most bills, though Senator May noted that the helmet bill was intended to address situations where rented helmets may have been damaged or consumers may not know their condition. Each bill was moved, seconded, and approved by the committee without opposition, with one bill reported to the Finance Committee and the others reported to first reading on the calendar. The meeting then adjourned after concluding legislative business.

Transcript Highlights:

• Your pharmaceutical used to only be 10 to 12% of the health care dollar.
• Phil Christophernelly here on behalf of the Pharmaceutical Care Management Association.
• I represent the Pharmaceutical Care Management Association.
• I represent the Pharmaceutical Care Management Association.
• Large pharmaceutical manufacturers. You know their names.

Summary: The committee first adopted the minutes from several prior 2025 meetings, then took up HB 574 by Rep. Spell, which updates the names of two organizations on the Mental Health Advocacy Service Board of Trustees. Rep. Spell explained it as a technical cleanup bill to correct the names of the Louisiana Mental Health Association and the Louisiana State Medical Society so the board’s membership records match current organization names. With no objections, HB 574 was reported favorably. The committee then heard HB 486, also by Rep. Spell, to join the Psychology Interjurisdictional Compact (PsyPact) and allow Louisiana psychologists to provide telepsychology and temporary in-person services across state lines. Rep. Spell and PsyPact representatives said the compact would expand access to mental health care, especially in rural areas, while maintaining standards and disciplinary oversight. The committee adopted amendments on fees and the effective date, and HB 486 was reported favorably with amendments. HB 198 by Rep. Eccles proposed a Medicaid reimbursement methodology for ambulatory surgical centers, using a Medicare-based rate to improve access for Medicaid patients needing specialty procedures. Amendments were adopted to add ophthalmology-related services and to cap reimbursement at the lesser of the outpatient hospital rate or 100% of the Medicaid rate, along with a technical amendment to address the fiscal note. Supporters from GI and ASC groups said the bill would improve access and lower long-term costs, and the bill was reported favorably with amendments. The committee spent the most time on HB 182 by Rep. Travis Johnson, which would require hospitals to ensure access to sexual assault forensic exams and related training. Johnson, law enforcement witnesses, and the Attorney General’s office emphasized the need for timely evidence collection, especially in rural areas, and said the current system leaves victims traveling long distances or losing evidence. Hospital and coroner witnesses supported the goal but opposed the bill as written, arguing it could impose duties on hospitals without enough trained personnel, funding, or a workable statewide training and coordination system; they urged a statewide coordinator, mobile SANE units, and clearer implementation. The bill was not finally disposed of in the portion of the meeting provided, and members discussed continuing to work on amendments and timing before floor consideration.

Transcript Highlights:

• Insurance is blaming pharmaceutical and also the hospitals.
• We're blaming the pharmaceuticals and the insurance industry.
• Insurance is blaming pharmaceutical and also the hospitals.
• We're blaming the pharmaceuticals and the insurance industry.
• Is there any change from the rest of the population in pharmaceuticals?

Keywords: 908, all

Summary: The committee met to review the history and current treatment of North Dakota health insurance mandates, with presentations from Blue Cross Blue Shield of North Dakota, Sanford Health Plan, the Public Employees Retirement System (PERS), and the Insurance Department. The discussion focused on how mandates apply differently to fully insured, self-funded, ACA, Medicaid, and PERS plans; how the state’s benchmark plan and federal essential health benefits affect coverage; and how the existing process requires cost-benefit analysis and, for certain measures, a PERS pilot period before broader application. Presenters also reviewed the long list of existing state mandates, including provider, beneficiary, and coverage requirements, and noted that many were enacted decades ago and have not been revisited despite changes in medical evidence and treatment options. Witnesses from the carriers argued that mandates should be reviewed periodically because some are outdated, can create unintended costs, and may not align with current medical guidance. Examples cited included PSA screening, off-label drug coverage, prior authorization rules, step therapy, and cost-sharing provisions for mental health and substance use treatment. They emphasized that carriers often cover services without a mandate when supported by clinical evidence, and that mandates can shift costs to employers and employees, especially in the fully insured small-group market. They also suggested possible policy improvements such as clearer mandate definitions, better transparency around cost-benefit analyses, a regular 10-year review of mandates, and more timely submission of proposals through the interim process. PERS and the Insurance Department highlighted a recurring tension over what counts as a mandate and when a measure triggers the state’s defrayal obligation under federal law. PERS described its interim committee process, the April 1 deadline for fiscal-impact proposals, and the limited pilot program used for certain measures, noting that only a few bills have gone through the full pilot process. The Insurance Department explained that it views new benefit mandates through the lens of the ACA benchmark plan and essential health benefits, distinguishing true new benefits, such as infertility coverage, from changes to existing benefits, such as telehealth or insulin cost-sharing caps. No votes were taken on policy changes; the meeting was informational, with members asking questions about costs, applicability, transparency, and whether a periodic mandate review should be established.

Transcript Highlights:

• That's not how we regulate aviation, it's not how we regulate pharmaceuticals, and it should not be how
• These regulations compound this problem by keeping the public in the dark.

Summary: The Assembly Transportation Committee heard an informational hearing on California’s newly finalized autonomous vehicle regulations, with DMV and CHP officials describing the updated framework and committee members pressing them on safety, enforcement, and first-responder impacts. DMV said the rules, effective April 28, 2026, expand reporting, create a phased permitting system from testing to deployment, add requirements for safety cases, remote operations, and first-responder coordination, and open a path for heavy-duty AV testing and deployment while still prohibiting oversized loads and hazardous materials. CHP said it worked with DMV on enforcement tools, first-responder interaction plans, and training local agencies on the new notice of noncompliance process. Members asked about crash data, immobilizations, freeway and construction-zone safety, weigh-station enforcement, and whether foreign licenses can qualify for remote assistants or drivers; DMV and CHP said the rules are intended to keep AVs accountable and that heavy-duty AVs will be held to the same roadway standards as human-driven commercial vehicles. A second panel focused on data collection and enforcement. Consumer attorneys argued the prior rules were too limited because DMV stopped collecting meaningful data once AVs moved from testing to deployment, making it difficult for the public and litigants to understand incidents; they supported the new regulations but urged that the collected information be made public. The industry association said California now has the nation’s most robust AV oversight, with monthly or quarterly reporting of collisions, system failures, immobilizations, harsh braking, vehicle miles traveled, and notices of noncompliance, plus broad DMV authority to restrict or suspend operations. In response to questions, the industry said it generally supports the new framework, believes the regulations are clear, and does not favor full federal preemption of state AV rules, though it wants federal standards for design, construction, and performance. A third panel addressed first-responder interaction and remote operations. The San Francisco Fire Department described repeated AV interference with emergency scenes and said AVs have generated hundreds of “sleeper calls,” where passengers fall asleep and trigger 911 responses; the department said these incidents consume significant staff time and it wants better protocols to reduce unnecessary dispatches. Waymo said it has trained thousands of public-safety personnel, maintains a 24/7 emergency line, uses geofencing/avoid-the-area messages, and can allow first responders to manually override or move vehicles when needed. Committee members asked about sleeper-call prevention, remote assistant licensing and drug testing, communication redundancies during outages, and how manual overrides work for vehicles without traditional controls; Waymo said it is collaborating with responders and that its vehicles are designed to reach a safe stop if connectivity is lost. The final panel began with testimony on heavy-duty autonomous vehicles. A transportation researcher said freight is essential to California’s economy and that heavy-duty AVs pose distinct safety risks because of their weight, stopping distance, and the potentially severe consequences of crashes or immobilizations on highways. He said the new regulations are important because they create a regulated pathway for heavy-duty AV deployment, require a safety case, set mileage thresholds, and add reporting categories that can serve as leading safety indicators. The hearing was still in progress when the transcript ended, with additional testimony expected from labor and industry witnesses on heavy-duty AV deployment.

Transcript Highlights:

• An example of this is the old Stewart Pharmaceutical Building, which is located across the street from
• These external pressures are now being compounded by state-imposed cost structures, particularly the

Summary: The Assembly Housing and Community Development Committee heard a long agenda of housing-related bills, beginning with AB 1892 on HOA/Davis-Stirling Act cleanup provisions. The author and sponsor said the bill would clarify HOA responsibilities for utility service repairs in common areas, align election notice timelines, and require electronic voting ballots to be sent at least 30 days before an election. No opposition was presented, and the bill was set aside to be taken up later when a quorum was available. The committee then heard AB 1708, which would revise the Homeless Housing, Assistance and Prevention (HHAP) program to give smaller cities a clearer role in regional homelessness planning and access to funding. Mayors and city representatives from Bellflower, Paramount, and other cities testified that smaller jurisdictions are spending significant local funds on shelters and services but lack direct access to HHAP dollars. Some larger-city and housing advocates opposed or were opposed unless amended, arguing the bill could add administrative burden, but committee members broadly supported the goal of including smaller cities in regional responses. Members also heard AB 2058 on factory-built housing, AB 2576 on historic-resource protections under SB 79, AB 1751 on missing-middle townhomes, AB 1924 on homelessness prevention, AB 2626 on waiving certain monitoring fees for at-risk affordable housing developments, and AB 2089 on welfare-exemption and recertification procedures for affordable housing. Testimony generally emphasized reducing duplicative local permitting for factory-built housing, protecting state and national historic resources while still allowing housing near transit, expanding ministerial approval for townhomes, creating a statewide homelessness-prevention strategy with accountability measures, giving HCD flexibility to waive fees to preserve financially stressed affordable housing, and streamlining property-tax exemption recertification. Several bills were voted out of committee, including AB 1751 and AB 2626, both passing on 8-0 and 7-0 votes respectively, while other measures were discussed with motions pending or held open for absent members.

Transcript Highlights:

• An example of this is the old Stewart Pharmaceutical Building, which is located across the street from
• These external pressures are now being compounded by state-imposed cost structures, particularly the

Keywords: 988, house, all

Transcript Highlights:

• Utilization pharmaceutical drugs is also a big cost driver there, but medical costs seem to be a big
• If you think about the CAGR, or the compound annual growth rate, of rates, of electricity rates, over

Keywords: 989, all

Summary: The committee was convened to review Idaho’s economic outlook and general fund revenue projections for fiscal years 2025-2028, with members instructed to submit “homework” revenue estimates by noon the next day so staff could compile committee averages and medians for deliberations and a final recommendation to JFAC. Opening remarks emphasized the committee’s constitutional charge, the use of the binder materials and online packet, and that the committee would meet again the next day to discuss and vote on the revenue projection recommendation. Staff and agency presentations focused on the state’s budget and revenue picture. Legislative Services Office staff described structural imbalance concerns, noting that statutory spending changes and earmarked sales tax distributions have crowded out flexibility, while cash reserves remain substantial. The Division of Financial Management’s economist explained the official revenue forecast, including revised treatment of sales tax and tax relief fund accruals, and said the forecast largely held steady overall even as corporate and individual income tax categories shifted. She also discussed the impact of the federal One Big Beautiful Bill Act on SALT deductions and said recent corporate collections had rebounded sharply, suggesting timing and behavior changes rather than a broad economic downturn. Outside economists and labor experts painted a generally stable to positive economic picture. Zions Bank’s economist said the Federal Reserve is likely near the end of major rate cuts, long-term rates and mortgage rates remain elevated, tariffs have risen sharply, but inflation has not yet shown broad tariff-driven acceleration; he described the national labor market as slowing but not contracting and said 2026 could be a rebuilding year. The Idaho Department of Labor reported that Idaho’s unemployment remains historically low, job growth is steady, wage growth is moderating from overheated pandemic-era levels, and the state’s labor market remains healthier and more balanced than the national picture. The committee also heard from Idaho Power’s economist, who began a presentation on broader economic conditions and utility-related demand trends before the transcript ended.

Transcript Highlights:

• The challenge is further compounded by our proximity to Mexico.
• I also note that I do not have any relationship to pharmaceutical companies or any other related entities

Bills: SB34, SB119, SB261, SB532, SB1035, SB1245, SB1247, SB1267, SB1442, SB1930, SB1948, SB2078, SB2112, SB2143, SB2155

Keywords: wildfire, wildfire mitigation, wildfire prevention, volunteer fire department, Texas A&M Forest Service, West Texas A&M University, prescribed burning, fuel loading, fuel reduction, firefighting equipment database, emergency communications, disaster preparedness, rural fire protection, asset hardening, natural resource management, emergency management, large wildfire risk, fire grant funding, fire suppression, Texas Legislature

Transcript Highlights:

• How do you heal from the compound grief of losing your community, your home, and your loved ones at the
• Labor costs, pharmaceutical costs, inflation, all increasing far more than the upcoming OCA limits.

Summary: The Assembly Health Committee held an informational hearing on the health impacts of wildfires and the effects on health care systems and access to care. The first panel focused on public health consequences, with testimony from UCLA and UCSF physicians, a community organizer, and an Altadena recovery leader. Witnesses described acute and long-term physical harms from wildfire smoke and ash, including asthma and COPD exacerbations, cardiovascular and stroke risks, pregnancy impacts, infection risk, and possible added hazards from lithium-ion battery fires. They also emphasized mental health effects such as anxiety, depression, PTSD, “firebrain,” and the need for psychological first aid, trauma-informed community networks, and youth-focused resilience programs. Community advocates stressed that Latine, Indigenous, undocumented, and Black communities face disproportionate harm because of language barriers, unsafe work conditions, lack of insurance, and exclusion from disaster aid, and they called for stronger language access, worker protections, permanent disaster relief, and better outreach. Committee members asked about air monitoring, masks, wind events, lithium-ion batteries, and how to reach communities with translation and emergency information. Panelists said AQI is useful but incomplete, that N95s help for smoke but P100 masks are needed for ash/asbestos exposure, and that communities should be warned to stay indoors and avoid windy dust-ups after fires. They also discussed the importance of building relationships during non-emergency periods, using text alerts and trusted community organizations, and providing culturally and linguistically appropriate information. Several members and witnesses highlighted the need for more research on long-term health effects, especially for people with chronic lung disease, workers who cannot stay indoors, and residents exposed to repeated disasters. The second panel addressed health care system response and access to care. DHCS and DMHC described emergency flexibilities used during the Southern California fires, including federal waivers, extended Medi-Cal renewal deadlines, reinstated coverage for some disenrolled members, suspension of prior authorization and prescription refill barriers, out-of-network access at in-network cost-sharing, and communication through websites, toll-free numbers, and social media. Hospital and community health center leaders described major operational strain: emergency room surges, canceled surgeries, dialysis disruptions, staff displacement, temporary housing needs, and financial losses. Huntington Health and AltaMed reported using incident command systems, temporary care spaces, bilingual and culturally tailored services, mobile clinics, infection control measures, and community health workers to keep care going. Members and witnesses also discussed the need for better disaster staffing pools, more flexible facility rules, stronger mental health coverage, child care planning, and statewide coordination for future emergencies; no formal votes were taken.

Transcript Highlights:

• So, to be clear, we're going to be appropriating funds to partner with the private pharmaceutical company
• Because my reading of it looks like it is using appropriated funds to give to a pharmaceutical company
• intent for this to be a temporary intervention or a permanent component of the state's approach to pharmaceutical
• Again, this is not about pharmaceutical access; this is about one drug that over 800,000 Oklahomans need
• I think insulin is a pharmaceutical, and we're talking about pharmaceutical access.

Bills: SJR47, SB1491, SB1579, SB1806, SB1552, SB483, SB63, SB137, SB346, SB514, SB1344, SB1360, SB1380, SB1437, SB1189, SB1217, SB1221, SB1262, SB1272, SB1325, SB1339, SB201

Keywords: voter ID, elections, constitutional amendment, Oklahoma, proof of identity, presidential electors, vacancies, oath of office, political party, property tax, valuation increase, taxpayer rights, homestead, protest process, foster care, adoption assistance, transitioning youth, Department of Human Services, voluntary services, county home rule charter

Bills: SJR47, SB1491, SB1579, SB1806, SB1552, SB483, SB63, SB137, SB346, SB514, SB1344, SB1360, SB1380, SB1437, SB1189, SB1217, SB1221, SB1262, SB1272, SB1325, SB1339, SB201

Keywords: voter ID, elections, constitutional amendment, Oklahoma, proof of identity, presidential electors, vacancies, oath of office, political party, property tax, valuation increase, taxpayer rights, homestead, protest process, foster care, adoption assistance, transitioning youth, Department of Human Services, voluntary services, county home rule charter